Cas no 54669-74-8 (Cyclohexanone, 2-[2-oxo-2-[3-(trifluoromethyl)phenyl]ethyl]-)

Cyclohexanone, 2-[2-oxo-2-[3-(trifluoromethyl)phenyl]ethyl]- structure
54669-74-8 structure
Product Name:Cyclohexanone, 2-[2-oxo-2-[3-(trifluoromethyl)phenyl]ethyl]-
CAS No:54669-74-8
MF:C15H15F3O2
MW:284.273615121841
CID:353975
PubChem ID:12270334
Update Time:2025-04-19

Cyclohexanone, 2-[2-oxo-2-[3-(trifluoromethyl)phenyl]ethyl]- Chemical and Physical Properties

Names and Identifiers

    • Cyclohexanone, 2-[2-oxo-2-[3-(trifluoromethyl)phenyl]ethyl]-
    • 2-[2-oxo-2-[3-(trifluoromethyl)phenyl]ethyl]cyclohexan-1-one
    • SCHEMBL11832840
    • 2-(m-Trifluoromethylphenacyl)cyclohexanone
    • DTXSID90483363
    • 54669-74-8
    • Inchi: 1S/C15H15F3O2/c16-15(17,18)12-6-3-5-10(8-12)14(20)9-11-4-1-2-7-13(11)19/h3,5-6,8,11H,1-2,4,7,9H2
    • InChI Key: BYLKHCBYQSZXNC-UHFFFAOYSA-N
    • SMILES: FC(C1=CC=CC(=C1)C(CC1C(CCCC1)=O)=O)(F)F

Computed Properties

  • Exact Mass: 284.10245
  • Monoisotopic Mass: 284.10241420g/mol
  • Isotope Atom Count: 0
  • Hydrogen Bond Donor Count: 0
  • Hydrogen Bond Acceptor Count: 5
  • Heavy Atom Count: 20
  • Rotatable Bond Count: 3
  • Complexity: 376
  • Covalently-Bonded Unit Count: 1
  • Defined Atom Stereocenter Count: 0
  • Undefined Atom Stereocenter Count : 1
  • Defined Bond Stereocenter Count: 0
  • Undefined Bond Stereocenter Count: 0
  • XLogP3: 3.2
  • Topological Polar Surface Area: 34.1?2

Experimental Properties

  • PSA: 34.14
Recommended suppliers
Shaanxi pure crystal photoelectric technology co. LTD
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
Shaanxi pure crystal photoelectric technology co. LTD
Handan Zechi Trading Co., Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
SunaTech Inc.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
SunaTech Inc.
煙臺(tái)朗裕新材料科技有限公司
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
Nanjing Jubai Biopharm
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Nanjing Jubai Biopharm